CCR2 抗体 (N-Term)
Quick Overview for CCR2 抗体 (N-Term) (ABIN1732433)
抗原
See all CCR2 抗体适用
宿主
克隆类型
标记
应用范围
- 
    
- 
                                            
抗原表位
 - AA 20-100, N-Term
 - 
                                            
特异性
 - Reacts with human ~42 kDa CCR2
 - 
                                            
纯化方法
 - Purified
 - 
                                            
免疫原
 - Synthetic peptide made to an N-terminal portion of the human CCR2 protein (within residues 20-100).
 - 
                                            
亚型
 - IgG
 
 - 
                                            
 - 
    
 - 
    
- 
                                            
应用备注
 - 
                        
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only :
- FC : 1/50 - ICC : 1/50 - WB : 1.0 μg/mL - 
                                            
限制
 - 仅限研究用
 
 - 
                                            
 - 
    
- 
                                            
状态
 - Liquid
 - 
                                            
缓冲液
 - PBS, glycerol 30 % , Sodium azide 0.1 %
 - 
                                            
储存液
 - Sodium azide
 - 
                                            
注意事项
 - This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
 - 
                                            
储存条件
 - -20 °C
 - 
                                            
储存方法
 - Store at -20°C. Avoid freeze-thaw cycles.
 
 - 
                                            
 - 
    
- CCR2 (Chemokine (C-C Motif) Receptor 2 (CCR2))
 - 
                                            
别名
 - C-C Chemokine Receptor Type 2 (CCR2 / CD192)
 - 
                                            
背景
 - Receptor for the CCL2, CCL7 and CCL13 chemokines. Transduces a signal by increasing intracellular calcium ion levels. Alternative coreceptor with CD4 for HIV-1 infection.
 - 
                                            
UniProt
 - P00338
 - 
                                            
途径
 - cAMP Metabolic Process, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
 
抗原
 -